STOCK TITAN

Prudential discloses 5.7% stake in Arcutis

Prudential Financial, Inc. reported beneficial ownership of 7,079,926 shares of Arcutis Biotherapeutics, Inc. common stock, representing 5.7% of the class as of 12/31/2025.

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Prudential Financial, Inc. reported beneficial ownership of 7,079,926 shares of Arcutis Biotherapeutics, Inc. common stock, representing 5.7% of the class as of 12/31/2025.

Prudential has sole voting and dispositive power over 45,000 shares and shared voting power over 6,381,022 shares, with shared dispositive power over 7,034,926 shares. The position is held through subsidiaries including Jennison Associates LLC, The Prudential Insurance Company of America, and Quantitative Solutions LLC. Prudential states the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of Arcutis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



PRUDENTIAL FINANCIAL INC
Signature:Richard Baker
Name/Title:Second Vice President
Date:02/13/2026

Keep reading